Successful 3rd International CytoSorb® Users Meeting
The 3rd International Cytosorbents User Meeting, held in Brussels in the run-up to ISICEM, one of the largest intensive care congresses in the world, delivered outstanding results.
107 experts from 23 countries presented the latest study results of their work with the Cytosorb blood purification adsorber and discussed them. Cytosorb has been used in approximately 11,000 treatments in nearly 6,000 patients.
Cytosorbents Europe GmbH, headquartered in Berlin, is a wholly owned subsidiary of CytoSorbents Corporation of Monmouth Junction, New Jersey, USA, where the CytoSorb product is manufactured. CytoSorb is the company’s flagship product, backed by more than 30 patent families.
Welcome: 6th International CytoSorb Users` Meeting
Subscribe to our newsletter now!
Get access to the CytoSorbents Community Area. The current newsletter contains a direct link to the CytoSorbents Community Area.